About FDNA

Learn more about our story, values, and team

Past, present, and future

Our Story

FDNA is the brainchild of the founders of Face.com, a company that developed a facial recognition technology and was later acquired by Facebook, who decided to harness the power of AI to analyze health conditions.

Since its inception in 2011, FDNA has invested over 10 years in developing its AI-powered technology, establishing clinical integrity, and curating the world’s largest repository of rare disease facial image data. This has enabled the company to support thousands of patients, families, and healthcare professionals in the diagnostic process.

Used by 70% of the world’s geneticists and thousands of other clinicians and researchers across 10,000 clinical sites in over 130 countries, FDNA’s next-generation phenotyping (NGP) technologies capture, structure, and analyze complex human physiological data to produce actionable insights.

Today, building on our heritage of excellence, we develop the most helpful and effective products that serve parents, patients, providers, researchers, pharma, and CROs. We are currently focused on establishing partnerships with healthcare professionals to build together a better healthcare business ecosystem.

We plan to grow our multi-modal AI capabilities to support video, audio, imaging systems, and other available input points, and to continue supporting parents, patients, and healthcare professionals in improving the diagnosis process and promoting access to affordable care.

With great AI power comes great responsibility & opportunity

Our Mission & Values

Developmental issues and rare disease are individually rare but collectively common.

People who struggle with developmental disabilities and rare diseases may feel alone in their journey. We see it as our mission to advocate for each individual and family, and help build a community that is stronger together. Stronger in supporting each other, stronger when working with the pharmaceutical industry, stronger when working to discover new therapies, and stronger when working with policymakers and health systems on providing access to care.

We believe in providing affordable access to care to everyone, and we build our technologies, products, and services, to fulfill that goal.

We leverage our broad national and international reach to provide free access to millions of children from all races and ethnicities around the world, to create the most diverse and accurate AI possible, that represents the beautiful mosaic of our diversity, in the US and worldwide.

We believe in the right to privacy and we architect our services to enable de-identified, safe, and secure data exchange between parents, patients, caregivers, researchers, and pharmaceutical services to expedite diagnosis and access to care.

What do we DO?

AI-Powered Diagnosis & Care Management Tools to Support Early Detection of Developmental Delays & Genetic Disorders

  • We empower parents, school nurses, and pediatric specialists to flag potential developmental, neurological, and genetic conditions, and connect with the right medical specialists, as early as possible.
  • FDNA offers a digital front door for healthcare providers, decision support tools for diagnosis and care management tools for therapy.
  • Our unparalleled data clearing house offers streamlined interoperability between healthcare providers, patients, and the pharmaceutical industry, including therapy services and Clinical Research Organizations (CROs).
  • FDNA’s innovative products like Child Development Checker, Face2Gene, Care Matcher, and the rest of the health providers suite, enable better diagnosis and care management.

Our team

Leadership

  • Sarah Savage
    Head of Product & Clinical

Sab members

Our Scientific Advisory Board

  • Dr. Madhuri Hedge
    PerkinElmer, Inc., Atlanta, GA, USA
  • Dr. David A. Chitayat, FABMG, FACMG, FCCMG, FRCPC
    SickKids Hospital, Toronto, Canada
  • Prof. Jill Clayton-Smith, MB ChB, MRCP, FRCP
    St Mary's Hospital, Manchester, England
  • Dr. Cynthia J.R. Curry
    Genetic Medicine Central California, Fresno, CA, USA
  • Prof. Dian Donnai, CBE, FMedSci, FRCP
    St Mary's Hospital, Manchester, England
  • Prof. Mordechai (Motti) Shochat, MD
    Sheba Medical Center, Tel-Hashomer, Israelk
  • Dr. Michael Baraitser
    London Medical Databases, London, England
  • Vivian J. Weinblatt, MS, CGC
    Arcadia University, Glenside, PA, USA
  • Prof. Dr. Gabriele Gillessen-Kaesbach, MD
    Director, Institut für Humangenetik, Lubeck, Germany
  • Dr. Himanshu Goel, MBBS, DM, FRACP
    University of Newcastle, Newcastle, Australia
  • Dr. Anna C. E. Hurst, MS
    University of Alabama, Birmingham, AL, USA
  • Dr. Valeria Capra, MD
    Istituto Giannina Gaslini, Genova, Italy
  • Dr. Annick Raas Rothschild
    Sheba Medical Center, Tel-Hashomer, Israel
  • Dr. Chad Haldeman-Englert
    Fullerton Genetics Center, Asheville, NC, USA
  • Prof. Koen Devriendt
    University Hospitals Leuven, Belgium
  • Dr. Omar Abdul-Rahman
    University of Nebraska Medical Center, Omaha, NE, USA
  • Dr. John Graham, ScD
    CSMC and Harbor-UCLA Medical Center, Torrance, CA, USA
  • Prof. Martin Zenker, MD
    Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany
  • Dr. Scott McLean
    Children’s Hospital of San Antonio, San Antonio, TX, USA
  • Dr. Antonio Martinez Carrascal
    Requena General Hospital, Valencia, Spain
  • Dr. Brian Chung
    Queen Mary Hospital, Hong Kong
  • Dr. Carlos Ferreira, FACMG
    Children's National Health System, Washington, D.C.
  • Dr. Elizabeth Roeder
    Children's Hospital of San Antonio, San Antonio, TX, USA
  • Dr. Oana Moldovan
    Centro Genética Médica St, Maria, Lisbon, Portugal
  • Dr. Lynne Bird
    Rady Children’s Hospital, San Diego, CA, USA
  • Dr. Margaret Adam
    University of Washington, Seattle, WA, USA
  • Dr. José Elías García-Ortiz
    CIBO, Guadalajara, Mexico
  • Dr. Matt Deardorff
    Children's Hospital of Philadelphia, PA, USA
  • Prof. Alessandra Renieri
    Università di Siena, Siena, Italy  
  • Dr. Alan Beggs
    Boston Children's Hospital, Boston, MA, USA
  • Dr. Pedro Sanchez
    Children's Hospital of Los Angeles, Los Angeles, CA
  • Dr. Ronny Kershenovich S.
    Hospital General de Mexico, Mexico City, Mexico
  • Dr. Steven A. Skinner
    Greenwood Genetic Center, Greenwood, SC, USA
  • Dr. John Carey
    University of Utah, Salt Lake City, UT, USA
  • Dr. Donald G. Basel
    Children's Hospital of Wisconsin, Milwaukee, WI, USA
  • Dr. June Anne Gold
    Loma Linda University Medical Center, Loma Linda, CA, USA
  • Dr. Ghayda Mirzaa
    Seattle Children's Research Institute Center for Integrative Brain Research, Seattle, WA, USA
  • Prof. Alain Verloes
    Hôpital Robert-Debré Ap-Hp, Paris, France
  • Dr. Andrea Superti-Furga
    University of Lausanne, Lausanne, Switzerland
  • Dr. Arnold Munnich
    Imagine Necker, France
  • Dr. Ben Solomon
    GeneDx, Gaithersburg, MD, USA
  • Dr. Bill Dobyns
    Seattle Children's Hospital, Seattle, WA, USA
  • Dr. Christina Fagerberg
    Odense University Hospital, Odense, Denmark
  • Prof. Giovanni Neri
    Istituto di Genetica Medica Universita Cattolica, Rome, Italy
  • Dr. Michael Hayden
    Teva Pharmaceutical Industries, Petah Tikva, Israel
  • Dr. Miguel del Campo
    Rady Children's Hospital, San Diego, CA, USA
  • Prof. Poh-San Lai
    National University of Singapore, Singapore
  • Dr. Tinatin Tkemaladze
    Tbilisi State Medical University, Tbilisi, Georgia
  • Dr. Giulia Pascolini
    Genetic Counselling Unit and Rare Skin Diseases Center Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome Italy
  • Dr. Yuri Zarate
    Arkansas Children's Hospital